ABAnnelie Brauner

Annelie Brauner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Annelie Brauner has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Milan Chromek

    Department of Clinical Microbiology,1 Astrid Lindgrens Children's Hospital,3 Department of Immunology and Transfusion Medicine, Karolinska Hospital, Stockholm, Sweden,5 Department of Pediatrics, Comenius University Medical School, Bratislava, Slovakia,2 Great Ormond Street Hospital for Children, London, United Kingdom4

    3 shared publications
  • A. Khalil

    Department of Clinical Microbiology, Microbiology and Tumorbiology Center

    2 shared publications
  • G. Jaremko

    Department of Pathology, Karolinska Hospital, Stockholm, Sweden

    2 shared publications
  • K. Tullus

    Astrid Lindgrens Children's Hospital

    2 shared publications
  • Kjell Tullus

    Department of Clinical Microbiology,1 Astrid Lindgrens Children's Hospital,3 Department of Immunology and Transfusion Medicine, Karolinska Hospital, Stockholm, Sweden,5 Department of Pediatrics, Comenius University Medical School, Bratislava, Slovakia,2 Great Ormond Street Hospital for Children, London, United Kingdom4

    2 shared publications
  • Olof Hertting

    Department of Women's and Children's Health Karolinska Institutet Stockholm Sweden

    2 shared publications

Latest Publications

  • Open Access

    Tissue Inhibitor of Metalloproteinase 1 Activates Normal Human Granulocytes, Protects Them from Apoptosis, and Blocks Their Transmigration during Inflammation

    by Milan Chromek, Kjell Tullus, Joachim Lundahl, Annelie Brauner

    Urinary levels of tissue inhibitor of metalloproteinase 1 (TIMP-1) higher than those of matrix metalloproteinase 9 (MMP-9) during acute pyelonephritis have previously been associated with a higher degree of acute inflammation and of postinfective renal scarring. The aim of the present study was to evaluate possible mechanisms by which TIMP-1 could affect the scarring process already during the acute phase of inflammation. The growth ofEscherichia coli, bactericidal activity of fresh human blood, and respiratory burst, spontaneous apoptosis, and trans-basement membrane migration of normal human granulocytes were studied in vitro in the presence of different concentrations of recombinant human TIMP-1. To imitate the “normal” environment during inflammation in the kidney, granulocytes were also incubated with a conditioned medium fromE. coli-stimulated renal epithelial cells. In order to compare our data with the in vivo situation, blood and urinary leukocyte levels were analyzed for 40 children with acute pyelonephritis, together with urinary MMP-9 and TIMP-1 levels. TIMP-1 at a concentration of 500 ng/ml increased the bactericidal activity of blood, increased the respiratory burst of granulocytes, decreased phosphatidylserine exposure and caspase 3 activity, which are features of spontaneous apoptosis, and inhibited granulocyte transmigration. Moreover, in the patients with pyelonephritis, MMP-9/TIMP-1 ratios in urine correlated with the degree of leukocyte transmigration. Thus, our data suggest that TIMP-1 specifically blocks the transmigration of granulocytes into urine. Entrapped and activated granulocytes, protected from apoptosis, might excessively destroy renal parenchyma and thus contribute to the pathogenesis of renal scarring following acute pyelonephritis.


  • Open Access

    Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Acute Pyelonephritis and Renal Scarring

    by Milan Chromek, Kjell Tullus, Olof Hertting, Georg Jaremko, Adli Khalil, Ying-Hua Li, Annelie Brauner

    The aim of the present study was to elucidate the role of matrix metalloproteinase-9 (MMP-9), and its main inhibitor tissue inhibitor of metalloproteinases-1 (TIMP-1), in acute pyelonephritis and the process of renal scarring. Urine samples from 40 children with acute pyelonephritis, 16 children at 6-wk follow-up and 15 children with nonrenal fever were analyzed using ELISA. MMP-9 and TIMP-1 levels were compared with the outcome of pyelonephritis as measured by renal static scintigraphy. A mouse model of acute ascending pyelonephritis was used to localize the sites of production and the kinetics of MMP-9 and TIMP-1 using immunohistochemistry and ELISA. Human renal epithelial A498 cells, primary mesangial cells and monocytic THP-1 cells were stimulated by Escherichia coli. MMP-9 and TIMP-1 mRNA was analyzed by reverse transcription-PCR (RT-PCR) and protein production by ELISA. We demonstrate a significant increase of MMP-9 and TIMP-1 in the urine of children with acute pyelonephritis. Both proteins were produced mainly by leukocytes, and TIMP-1 also by resident kidney cells. Cells reacted differently after stimulation by bacteria. In mesangial cells and monocytes a decreased constitutive TIMP-1 production was found, which was in contrast to epithelial cells. Out of 40 children with pyelonephritis, 23 had higher urinary TIMP-1 than MMP-9 levels. These children had significantly more severe changes in both acute and follow-up scintigraphy scans indicating higher degree of acute tissue damage and renal scarring. Thus, our findings suggest an association between TIMP-1 and the process of renal scarring.


  • Open Access

    Enhanced chemokine response in experimental acuteEscherichia colipyelonephritis in IL-1β-deficient mice

    by O. Hertting, A. Khalil, G. Jaremko, M. Chromek, Y.‐H. Li, M. Bakhiet, T. Bartfai, K. Tullus, A. Brauner

    The aim of the present study was to investigate the effects of IL‐1β and Escherichia coli on the expression and secretion of MIP‐2, the mouse equivalent to human IL‐8, MCP‐1 and RANTES in the kidneys of mice with acute pyelonephritis. Female Bki NMRI, as well as IL‐1β deficient mice and their wild‐type littermates, were transurethrally infected with either E. coli CFT 073 or injected with NaCl 0·9% (w/v) and thereafter obstructed for 6 h. The Bki NMRI mice were killed at 0, 24, 48 h and 6 days and the IL‐1β‐deficient mice at 48 h. Chemokine mRNA and protein levels peaked at 24 h for the tested chemokines with the mRNA expression localized in the tubular epithelial cells and for MIP‐2 also in neutrophils. Obstruction per se, also induced a chemokine expression similar to E. coli infection although at a lower level. Interestingly, MIP‐2 levels were higher in the IL‐1β deficient mice as compared with the wild‐type littermates. Likewise, the inflammatory changes were more frequent and, when present, more widespread in the IL‐1β‐deficient mice than in the wild‐type mice. Stimulation of a human renal tubular epithelial cell line (HREC), A498 and of primary human mesangial cells (HMC) with the same bacterial antigen depicted gene expression of the same chemokines. A rapid release of IL‐8 and MCP‐1 was observed from both cell types. RANTES response was delayed both in the HREC and the HMC. We conclude that acute E. coli pyelonephritis induces a MIP‐2/IL‐8, MCP‐1 and RANTES expression and secretion localized primarily to the epithelial cells and that this production is confirmed after in vitro stimulation with the same bacterial antigen of human epithelial and mesangial cells. Blockade of induction of chemokine response may thus be an attractive target for possible therapeutic intervention.


  • Open Access

    Capd Peritonitis Induces the Production of a Novel Peptide, Daintain/Allograft Inflammatory Factor-1

    by Annelie Brauner, Olof Hertting, Eva Alkstrand, Elvi Sandberg, Milan Chromek, Zheng-Wang Chen, Claes-Göran Östenson

    To study the occurrence of a novel macrophage-derived peptide, daintain/allograft inflammatory factor-1 (AIF-1), in dialysate from continuous ambulatory peritoneal dialysis (CAPD) patients at commencement and after a follow-up period of therapy and during peritonitis. In addition, we studied peptide production in response to bacterial stimulation of monocytes and macrophages. Peritoneal fluid and supernatants from cells stimulated with different bacteria were analyzed for daintain/AIF-1. Peritoneal fluid was obtained from 5 patients at commencement of CAPD therapy and during 8 weeks follow-up, and from 14 patients (10 males, 4 females) during CAPD peritonitis and during the noninfected steady state. All patients were admitted to the Karolinska Hospital. A human monocyte cell-line, THP-1 was differentiated to macrophages, and both monocytes and macrophages were stimulated with live and heat-inactivated Escherichia coli, Staphylococcus aureus, and S. epidermidis Cells were also stimulated with interleukin (IL)-1β and interferon gamma (IFNγ). Daintain/AIF-1 was analyzed with radioimmunoassay technique and IL-8 with enzyme immunoassay technique. An increased production of daintain/AIF-1 was observed in the first spent dialysate in the newly started CAPD patients, with a decrease during the follow-up period (p < 0.05). During peritonitis, the first spent dialysate revealed significantly higher levels of daintain/AIF-1 (3.9 ng/mL) compared to the noninfected state (0.8 ng/mL), with production normalizing after 9 – 12 days. Bacterial stimulation with E. coli, S. aureus or S. epidermidi sinduced higher daintain/AIF-1 response in monocytes compared to macrophages (p < 0.05). Live bacteria induced higher production of the peptide compared to heat-inactivated bacteria (p < 0.05). Interleukin-1β and IFNγ were used to stimulate monocytes and macrophages; however, no daintain/AIF-1 production was found, although increased IL-8 levels were detected. CAPD peritonitis induces a high and prominent daintain/AIF-1 response. Bacteria are able to induce a response of the peptide from monocytes and macrophages, and it is likely that the virulent parts of the bacteria are heat-labile structures. The early rise in daintain/AIF-1 might be used as a marker of CAPD peritonitis.


  • Open Access

    Activation of macrophage nuclear factor-κB and induction of inducible nitric oxide synthase by LPS

    by Ying-Hua Li, Zhong-Qun Yan, Annelie Brauner, Kjell Tullus

    Chronic lung disease (CLD) of prematurity is a major problem of neonatal care. Bacterial infection and inflammatory response have been thought to play an important role in the development of CLD and steroids have been given, with some benefit, to neonates with this disease. In the present study, we assessed the ability of lipopolysaccharide (LPS) to stimulate rat alveolar macrophages to produce nitric oxide (NO), express inducible nitric oxide synthase (iNOS) and activate nuclear factor-κB (NF-κB) in vitro. In addition, we investigated the impact of dexamethasone and budesonide on these processes. Griess reaction was used to measure the nitrite level. Western blot and a semi-quantitative RT-PCR were performed to detect iNOS expression. Electrophoretic mobility shift assay (EMSA) was performed to analyze the activation of NF-κB. We found that LPS stimulated the rat alveolar macrophages to produce NO in a dose (≥10 ng/ml) and time dependent manner (p < 0.05). This effect was further enhanced by IFN-γ (≥10 IU/ml, p < 0.05), but was attenuated by budesonide (10-4–10-10 M) and dexamethasone (10-4–10-6 M) (p < 0.05). The mRNA and protein levels of iNOS were also induced in response to LPS and attenuated by steroids. LPS triggered NF-κB activation, a mechanism responsible for the iNOS expression. Our findings imply that Gram-negative bacterial infection and the inflammatory responses are important factors in the development of CLD. The down-regulatory effect of steroids on iNOS expression and NO production might explain the beneficial effect of steroids in neonates with CLD.


  • Escherichia coli-induced expression of IL-1α, IL-1β, IL-6 and IL-8 in normal human renal tubular epithelial cells

    by A. Brauner, M. Söderhäll, S. H. Jacobson, J. Lundahl, U. Andersson, J. Andersson

    The aim of the present study was to investigate whether the IL-1 family cytokines, in addition to IL-6 and IL-8, could be induced in normal human cortical epithelial cells in response to bacterial stimuli. Human renal tissue was obtained from 9 patients undergoing elective tumour nephrectomy. Renal cortical epithelial cells of tubular origin were prepared from the unaffected tissue. The proximal tubular cells were stimulated for 2, 6 and 24 h with a heat-inactivated pyelonephritogenic Escherichia coli strain DS-17. Cultured unstimulated tubular cells served as controls. IL-1α, IL-1β, IL-1 receptor antagonist, IL-6, IL-8, IL-10, TNF-α, G-CSF and GM-CSF were analysed using immunohistochemistry at the single cell level. The nonstimulated cells were found to express low levels of IL-6 and IL-8 (mean value < 3% of total cells). In contrast, E. coli exposure resulted in significantly increased incidences of IL-6 and IL-8 expressing cells (mean values ≈18% of total cells) peaking within two hours of stimulation (P < 0·008 and P < 0·02 versus non-stimulated cells, respectively). A gradual decrease was thereafter observed at 6 and 24 h, respectively, although persistently higher compared to controls. A different kinetic response was found for IL-1α, IL-1β and IL-1 receptor antagonist-expressing cells, which peaked 24 h after E. coli stimulation (mean values 3–10%) (P < 0·008, P < 0·02, P < 0·02 versus non-stimulated cells, respectively). Low levels of TNF-α and GM-CSF were found in 3 of the 9 donated epithelial cells, peaking at 2 h, and IL-10 and G-CSF producing cells in 1 patient each. In conclusion we found that heat-inactivated pyelonephritic E. coli induced a proinflammatory cytokine response in the normal human proximal tubular cells including the IL-1 family, IL-6 and IL-8.


  • Open Access

    Renal cytokine responses in acuteEscherichia colipyelonephritis in IL-6-deficient mice

    by A. Khalil, K. Tullus, T. Bartfai, M. Bakhiet, G. Jaremko, A. Brauner

    The aim of this study was to investigate the influence of IL‐6 on mortality, bacterial growth and cytokine expression in experimental acute pyelonephritis. Female IL‐6‐deficient mice and their wild‐type counterparts, 8–10 weeks old, were infected with Escherichia coli CFT 073 or injected with NaCl 0·9% (w/v) via the urethra and thereafter obstructed for 6 h. Animals were killed at 48 h, 6 days or 8 weeks and cytokine and bacterial renal levels were assessed at each time point. We found that IL‐6‐deficient mice had increased mortality and extensive renal bacterial growth on day 6, compared with wild‐type mice (P < 0·05) and the histopathological changes were generally more severe and widespread in the IL‐6‐deficient mice. Peak mRNA expression of IL‐1β, IL‐4, IL‐10, IL‐12 and interferon‐gamma (IFN‐γ) occurred 48 h after infection in both IL‐6 knock out and wild‐type mice. Transforming growth factor‐beta (TGF‐β) levels also peaked at 48 h in E. coli‐infected wild‐type mice, while in the IL‐6‐deficient strain both TGF‐β mRNA and protein levels were significantly lower at 48 h than wild‐type levels (P < 0·0008 and P < 0·03, respectively) and remained stationary throughout the study period. Animals injected with NaCl 0·9% (w/v) displayed a similar decrease in TGF‐β expression (P < 0·02). When splenocytes from the IL‐6‐deficient mice were incubated with murine recombinant IL‐6, TGF‐β levels increased to those of wild‐type mice. No increase was observed when splenocytes from wild‐type mice were incubated with the same doses of rIL‐6. We therefore conclude that IL‐6 plays an important role in bacterial clearance and directly influences the TGF‐β levels in experimental acute pyelonephritis. We also demonstrate that urethral obstruction per se induces an increase in TGF‐β the magnitude of which is decreased in IL‐6‐deficient mice.